AbbVie Breaks Ground on US API Manufacturing Facility
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Active Pharmaceutical Ingredient (API)
Cambrex Expands Peptide Manufacturing Capabilities in US
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
Nippon Shokubai to Boost Nucleic Acid Drug API Output Tenfold
Nippon Shokubai recently announced plans to expand its GMP-compliant manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) tenfold.
Ecolab Life Sciences Opens Bioprocessing Laboratory in US
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
HAS Acquires Cerbios-Pharma
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
Lonza Launches Innovaform Accelerator
Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
Sandoz Opens Antibiotic Production Facility in Austria
Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
Integrated Continuous Manufacturing in Pharmaceuticals
An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.
A New Standard of Collaboration for the Pharmaceutical Industry
Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the global biopharmaceutical industry, including active pharmaceutical ingredient (API) development, scale-up and cGMP manufacturing, as well as antibody drug conjugate (ADC) R&D and clinical-scale GMP manufacturing.
Breakthrough Supply Chains for the Pharmaceutical Industry
The pharmaceutical industry is a truly global and complex network of ingredients and materials suppliers, manufacturers, distributors for a variety of products ranging from vaccines to antibiotics and to therapeutic drugs for customers/patients.
